News that Valeant Pharmaceuticals International Inc. had a suitor sniffing around has given the greatly-depressed stock a small bump in recent days, but analysts are skeptical that the drug company could attract other offers.
Recent reports from The Wall Street Journal say that Takeda Pharmaceutical Co. Ltd. and private equity fund TPG...